Clinical Kidney Journal

Article	Citations
Prolonged normothermic perfusion: a promising approach to kidney transplantation	217
A puzzling renal Fanconi syndrome	108
Donor-derived membranous nephropathy	93
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	69
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	68
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	68
Can exercise improve outcomes for frail haemodialysis patients?	62
Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase	60
The “Leicester, Leicestershire, and RUtland Chronic Kidney Disease Integrated Care Delivery Project” (LUCID) programme update: the impact on novel kidney therapies	60
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	59
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	57
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	56
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	55
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	51
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	51
Making use of avacopan in clinical practice	50
Ten tips on how to manage kidney health in migrants and refugees	48
Ten tips on management of BK nephropathy in kidney transplant patients	47
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	46
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	45
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	43
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	43
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training	42
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	42
10 tips on performing economic evaluation in kidney disease	41

Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	41
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	41
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	41
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	41
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	39
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort	39
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy	37
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	37
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis	37
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	36
Erythroferrone is associated with the hepcidin-to-ferritin ratio and cardiovascular mortality in chronic kidney disease	36
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	36
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	35
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	35
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	34
Fish oil supplements in patients with chronic kidney disease	34
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	34
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	33
Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction	33
Clonal hematopoiesis of indeterminate potential is associated with increased cardiovascular risk in chronic kidney disease	32
Biomarkers in clinical epidemiology studies	32
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	32
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	31
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients	31
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis	31
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial	31
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients	31
Complications on the feeding artery after an arterio-venous fistula closure in patients after kidney transplantation – a national cohort study	31
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation	30
Introduction to new CKJ section: In Context – in collaboration with YNP	30
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients	29
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials	29
Acute kidney injury due to inhalation of metal fumes	28
Rituximab-based therapy in infection-associated severe crescentic proliferative glomerulonephritis with monoclonal immunoglobulin deposition	28
Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’	28
The integrated care model: facilitating initiation of or transition to home dialysis	28
Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy	27
Addressing cognitive impairment in peritoneal dialysis: a systematic review and meta-analysis of prevalence, risk factors, and outcomes	27
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease	27
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	27
Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future	27
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study	26
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study	26
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?	26
Short versus long corticosteroid therapy for immune checkpoint inhibitors–induced acute tubulointerstitial nephritis	25
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	25
Clinical outcomes of glucagon-like peptide-1 receptor agonist therapy in kidney transplant recipients: a systematic review and meta-analysis	24
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review	24
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part	24
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	24

Renal function is highly associated with podiatric risk in diabetic patients	23
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study	23
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications	23
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes	22
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease	22
Genetic and clinical characterization of familial renal glucosuria	22
Glucose monitoring during hemodiafiltration: a comparison of continuous, capillary, and dialysis-line measurements	22
Ultrafiltration rate and mortality in patients undergoing extended-hours haemodialysis	22
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease	22
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease	22
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time	22
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up	22
Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study	22
Health-related quality of life in people with autosomal dominant polycystic kidney disease: a systematic review	21
The role of low health literacy in shared treatment decision-making in patients with kidney failure	21
The Many Faces of NELL1 MN	21
Fibrillary glomerulonephritis: an observational study of clinical-pathological features and outcomes in patients from a multi-institutional cohort	21
Estimating 24-hour urine phosphate excretion from spot urine	20
A 20-year follow-up study of identical twin sisters with immunoglobulin A nephropathy	20
What to do with key cardiovascular drugs when kidney function worsens?	20
Hemodiafiltration beyond the CONVINCE trial	20
Induction therapy for class I/II lupus nephritis with glucocorticoid monotherapy associates with higher relapse and poorer kidney outcomes	20
Correction to: Decongestion in patients with advanced chronic kidney disease coexisting with heart failure	20
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing	20
Understanding and targeting senescence in kidney disease	20
Remote management of anaemia in patients with end-stage kidney disease using a wearable, non-invasive sensor	20
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”	20
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants	19
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases	19
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease	19
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial	19
Mucosal-associated invariant T cells and the gut–kidney axis: a review	19
RNA therapeutics in kidney diseases: prospects and current status	19
Designing qualitative research with value in the clinical and epidemiological context: what, why and how	19
Urgent initiation of hemodialysis versus peritoneal dialysis in severe hyperkalemia: a prospective study	19
Thrombotic microangiopathy after kidney transplantation: diagnosis and management strategies	19
Personalizing electrolytes in the dialysis prescription: what, why and how?	19
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy	18
Fatigue across different chronic kidney disease populations: experiences and needs of patients	18
Potassium management and heart failure: a nephrologist's perspective	18
Hereditary kidney tumor syndromes: structured evaluation of a questionnaire-based approach	18
Frailty assessment in kidney transplantation: insights from a European survey	18
Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial	18
Predicting prognosis in ANCA-associated vasculitis with kidney involvement	18
Genetic testing in focal segmental glomerulosclerosis: in whom and when?	18
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	18
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies	18
Novel NUP160 mutations related to simultaneous congenital nephropathy and ovarian insufficiency	18
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment	17
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease	17
Dynamic prediction of kidney allograft and patient survival using post-transplant estimated glomerular filtration rate trajectory	17
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	17
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group	17
Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis	17
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies	17
Implementing a model of integrated CKD management between primary and secondary care	17
Correction to: Clinical implications of mineralocorticoid receptor overactivation	17
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury	17
Decoy receptors as biomarkers for exploring aetiology and designing new therapies	17
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury	17
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	17
Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?	17
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study	17
Integrative analysis of the association between circadian rhythm and lupus nephritis	17
The role of blood purification therapies in the treatment of chronic kidney disease–associated pruritus: a systematic review	17
Gamified renal point-of-care ultrasound to promote recruitment and anatomical competence in nephrology	17
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study	16
Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety	16
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction	16
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21	16
Management of hypertension in patients with cancer: challenges and considerations	16
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease	16
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up	16
Novel equations for estimating intraperitoneal pressure among peritoneal dialysis patients	16
Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR	15
Executive summary of the European consensus report on the diagnosis and treatment of Monoclonal Gammopathy of Renal Significance	15
New and old GFR equations: a European perspective	15
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study	15
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis	15
Subcutaneous Ofatumumab for remission maintenance in pediatric idiopathic nephrotic syndrome: a case series	15

Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis	15
Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome	15
Ageing meets kidney disease	15
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study	15
Which equation and which biomarker should be used in the Kidney Failure Risk Equation? A comparative analysis in the CKD-REIN cohort	15
Multiparametric MRI: can we assess renal function differently?	15
Preserving residual kidney function in peritoneal dialysis: from conventional approaches to contemporary practice	15
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection	14
Sodium–glucose co-transporter inhibitors, refractory hypomagnesaemia and recurrent genital mycotic infections	14
Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease	14
Prospective study of the effect of rituximab on kidney function in membranous nephropathy	14
Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort	14
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidence	14
Correction to: Moving on obesity treatment in CKD: inertia is unjustified	14
Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD	14
Personalized peritoneal dialysis prescription—beyond clinical or analytical values	14
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients	14
A review of supportive care for older people with advanced chronic kidney disease	14
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people	14
Preferences for healthcare decisional control in older people with chronic kidney disease in the UK indicate strong inclinations towards active and collaborative approaches	14
Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021	14
Association of albuminuria with incident atrial fibrillation in healthy older adults	14
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort	14
COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic	14
Performance of creatinine and cystatin C-based equations for estimating high levels of glomerular filtration rate in Congolese adults with sickle cell disease	14
Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study	14
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR	14
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding	14
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease	13
Intra-individual fluctuations in alkaline phosphatase predict mortality and CKD progression: insights from a large CKD cohort	13
Mechanisms and treatment of obesity-related hypertension—Part 2: Treatments	13
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices	13
The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons	13
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?	13
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab	13
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor–associated membranous nephropathy	13
Performance of an interstitial glucose monitoring device in patients with type 1 diabetes during haemodialysis	13
Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients	13
Urinary microvesicles: a window into the kidney	13
Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort s	13
2025 Update on resistant hypertension in CKD: where do we stand and where do we go?	13
New trials in resistant hypertension: mixed blessing stories	13
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally accepted	13
Immobilization-associated hypercalcaemia in patients with malignancy in the hospital setting	13
Citrullinated histone H3 identifies neutrophil extracellular trap formation and correlates with renal disease activity in ANCA-associated vasculitis	13
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants	13
Prophylactic proton pump inhibitor usage and new-onset acute kidney injury in critically ill patients: a retrospective analysis	13
Hyponatremia and the risk of sepsis in the setting of chronic kidney disease not on dialysis	13
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements	13
Ten tips to teach learners to love nephrology (and recruit the next generation)	12
Healthy aging and aging-related kidney diseases: lessons from centenarians	12
Malignancies and glomerulonephritis: when to suspect and when to screen?	12
Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room	12
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect	12
Associations between iron markers with hemoglobin and outcomes in peritoneal dialysis patients: results from the PDTAP study	12
Disturbance in the potential cardiovascular–bone–skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study	12
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease	12
International variations in chronic kidney disease patients’ pain experience and its management	12
Correction to: Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy	12
Epigenetic mechanisms of salt-sensitive hypertension	12
Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study	12
The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? (The CON part)	12
Estimation of glomerular filtration rate in cardiorenal patients: a step forward	12
Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients	12
Uraemic burden index: a novel predictor of pre-emptive kidney transplant outcome	12
Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis	12
Anti-nephrin antibody: a potential biomarker of minimal change disease	12
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy	12
Correction to: Using artificial intelligence to predict mortality in AKI patients: a systematic review/meta-analysis	12
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes	12
Circulating metabolites associated with kidney function decline and incident CKD: a multi-platform population-based study	12
History of creatinine clearance: tribute to a forerunner	12
The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy	11
Real-world analysis of the impact of finerenone on estimated glomerular filtration rate and albuminuria in patients with diabetic kidney disease	11
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial	11
Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort	11
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort	11
Safety and clinical impact of SGLT2 inhibitor in patients undergoing peritoneal dialysis: a target-trial emulation study	11
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review	11
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome	11
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients	11
The effect of standard percutaneous nephrolithotomy, miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery on biomarkers of renal injury: a randomized clinical trial	11
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease	11
Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease	11
An update on absolute and relative indications for dialysis treatment modalities	11
A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients	11
Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019	11
Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity	11
Alfacalcidol plus calcium versus cholecalciferol in glucocorticoid-exposed children with nephrotic syndrome: a randomized controlled trial	11
Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China	11
Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study	11
Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis	11
Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients	11
Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidne	11
National survey among French adult nephrologists on red blood cell transfusion in the early post–kidney transplantation period: time for evidence-based guidance	11